InvestorsHub Logo
Followers 44
Posts 10448
Boards Moderated 0
Alias Born 01/13/2016

Re: None

Sunday, 11/08/2020 9:11:39 AM

Sunday, November 08, 2020 9:11:39 AM

Post# of 459928
Let’s assume I am right and that many forces didn’t want any competition for
Biogen’s aduscamanrob before it was approved..

What do those forces do now?

What are there choices?

Get out of the game completely..or

Find a new champion.. they all know Anavex agonizes the S1r..

We have proved that beyond doubt..
Our MOA is fact Jack.

There is no doubt that the S1r is a postibe chaperone homeostasis protein..
Decades of proof through drug use and clinical trials by Anavex and other Pharma researchers..ZERO doubt..
Not an argument..

It’s a multi billion dollar play..
They control the market and MM with Anavex..no they didn’t get an IPO with cheap stock.. but our stock is still below one billion..they can accumulate all the Anavex stock they want up to $1 billion.. tens of millions of shares..I would think..
If they get in before RETt Symdrome results announced..

Where Elise do they go?

Very few choices for big players and cNS disease..



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News